190 related articles for article (PubMed ID: 15485748)
21. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis.
Fagard RH; Cornelissen VA
J Hypertens; 2007 Nov; 25(11):2193-8. PubMed ID: 17921809
[TBL] [Abstract][Full Text] [Related]
22. Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements.
Mancia G; Bombelli M; Brambilla G; Facchetti R; Sega R; Toso E; Grassi G
Hypertension; 2013 Jul; 62(1):168-74. PubMed ID: 23716584
[TBL] [Abstract][Full Text] [Related]
23. [Prognostic importance of white coat and masked hypertension].
Gustavsen P; Hansen TW
Ugeskr Laeger; 2009 Jun; 171(24):2019-22. PubMed ID: 19523366
[TBL] [Abstract][Full Text] [Related]
24. Relationship between insulin resistance and end-organ damage in white coat hypertension.
Tunçkale A; Aran SN; Karpuz H; Dirican A
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1011-6. PubMed ID: 15533726
[TBL] [Abstract][Full Text] [Related]
25. Follow-up clinic and ambulatory blood pressure in untreated white-coat hypertensive patients (evaluation after 2-5 years).
Polónia JJ; Santos AR; Gama GM; Basto F; Bettencourt PM; Martins LR
Blood Press Monit; 1997 Dec; 2(6):289-295. PubMed ID: 10388905
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
[TBL] [Abstract][Full Text] [Related]
27. Prognostic relevance of masked hypertension in subjects with prehypertension.
Pierdomenico SD; Pannarale G; Rabbia F; Lapenna D; Licitra R; Zito M; Campanella M; Gaudio C; Veglio F; Cuccurullo F
Am J Hypertens; 2008 Aug; 21(8):879-83. PubMed ID: 18464744
[TBL] [Abstract][Full Text] [Related]
28. Relationship between aortic stiffness and cardiovascular risk factors in a population of normotensives, white-coat normotensives, white-coat hypertensives, sustained hypertensives and diabetic patients.
Silva JA; Barbosa L; Bertoquini S; Maldonado J; Polónia J
Rev Port Cardiol; 2004 Dec; 23(12):1533-47. PubMed ID: 15732656
[TBL] [Abstract][Full Text] [Related]
29. Differences between diabetic and non-diabetic hypertensive patients with first acute non-ST elevation myocardial infarction and predictors of in-hospital complications.
Colivicchi F; Mettimano M; Genovesi-Ebert A; Schinzari F; Iantorno M; Melina G; Santini M; Cardillo C; Melina D
J Cardiovasc Med (Hagerstown); 2008 Mar; 9(3):267-72. PubMed ID: 18301144
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of small-artery structure in hypertension.
Rizzoni D; Porteri E; Boari GE; De Ciuceis C; Sleiman I; Muiesan ML; Castellano M; Miclini M; Agabiti-Rosei E
Circulation; 2003 Nov; 108(18):2230-5. PubMed ID: 14557363
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of ventricular repolarization prolongation in resistant hypertension: a prospective cohort study.
Salles GF; Cardoso CR; Muxfeldt ES
J Hypertens; 2009 May; 27(5):1094-101. PubMed ID: 19390353
[TBL] [Abstract][Full Text] [Related]
32. [Day-night differences of arterial pressure in "white coat" arterial hypertension].
Mora-Maciá J; Ocón Pujadas J; Díaz Gómez JM; del Río Pérez G
Rev Clin Esp; 1993 Jan; 192(1):11-5. PubMed ID: 8465023
[TBL] [Abstract][Full Text] [Related]
33. [White-coat hypertension].
Yamashita S
Nihon Rinsho; 2014 Aug; 72(8):1410-4. PubMed ID: 25167744
[TBL] [Abstract][Full Text] [Related]
34. Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart Study.
Tientcheu D; Ayers C; Das SR; McGuire DK; de Lemos JA; Khera A; Kaplan N; Victor R; Vongpatanasin W
J Am Coll Cardiol; 2015 Nov; 66(20):2159-2169. PubMed ID: 26564592
[TBL] [Abstract][Full Text] [Related]
35. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
Okin PM; Devereux RB; Gerdts E; Snapinn SM; Harris KE; Jern S; Kjeldsen SE; Julius S; Edelman JM; Lindholm LH; Dahlöf B;
Circulation; 2006 Mar; 113(12):1588-96. PubMed ID: 16534012
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of ambulatory blood pressure in hypertensive patients with history of cardiovascular disease.
Fagard RH; Thijs L; Staessen JA; Clement DL; De Buyzere ML; De Bacquer DA
Blood Press Monit; 2008 Dec; 13(6):325-32. PubMed ID: 18756173
[TBL] [Abstract][Full Text] [Related]
37. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.
Ohkubo T; Kikuya M; Metoki H; Asayama K; Obara T; Hashimoto J; Totsune K; Hoshi H; Satoh H; Imai Y
J Am Coll Cardiol; 2005 Aug; 46(3):508-15. PubMed ID: 16053966
[TBL] [Abstract][Full Text] [Related]
38. White coat effect, blood pressure and mortality in men: prospective cohort study.
Strandberg TE; Salomaa V
Eur Heart J; 2000 Oct; 21(20):1714-8. PubMed ID: 11032699
[TBL] [Abstract][Full Text] [Related]
39. Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study.
Olsen MH; Wachtell K; Ibsen H; Lindholm LH; Dahlöf B; Devereux RB; Kjeldsen SE; Oikarinen L; Okin PM;
J Hypertens; 2006 Apr; 24(4):775-81. PubMed ID: 16531808
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of prolonged ventricular repolarization in hypertension.
Schillaci G; Pirro M; Ronti T; Gemelli F; Pucci G; Innocente S; Porcellati C; Mannarino E
Arch Intern Med; 2006 Apr; 166(8):909-13. PubMed ID: 16636218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
